Skip to content

Clinical trials

Phase 1 Glioma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 1 Country / region: Canada Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20121
20153
20161
20181
20191
20211
20222
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting7
Completed5
Recruiting3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Cellectar Biosciences, Inc.2
Nationwide Children's Hospital2
Pfizer2
Celgene1
Deciphera Pharmaceuticals, LLC1
Novartis Pharmaceuticals1
Sunnybrook Health Sciences Centre1
Thallion Pharmaceuticals1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma17
Brain Neoplasms7
Glioblastoma7
Diffuse Intrinsic Pontine Glioma5
Melanoma5
Carcinoma, Non-Small-Cell Lung4
Astrocytoma3
Breast Neoplasms3
Ependymoma3
Gliosarcoma3

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.